Benign acute childhood myositis

Fatma Müjgan Sonmez1, Murat Cakir, Seker Yayla

  • 1Department of Child Neurology, Faculty of Medicine, Karadeniz Technical University, TR-61080 Trabzon, Turkey. fmaynacif@dr.com

Insights

Benign acute childhood myositis is a self-limiting condition in children, characterized by elevated muscle enzymes and rapid recovery. Awareness is key for pediatricians to avoid misdiagnosis and unnecessary tests.

Area of Science:

  • Pediatric Neurology
  • Pediatric Infectious Diseases
  • Pediatric Rheumatology

Background:

  • Benign acute childhood myositis (BACM) is an inflammatory condition affecting children.
  • It presents with acute onset of muscle pain and difficulty walking.
  • Prompt diagnosis is essential to prevent unnecessary investigations.

Purpose of the Study:

  • To evaluate the clinical and laboratory findings of benign acute childhood myositis.
  • To highlight the importance of recognizing BACM for appropriate pediatric care.

Main Methods:

  • Retrospective analysis of six pediatric patients diagnosed with BACM.
  • Evaluation of clinical presentations and laboratory findings, including serum creatine kinase and aspartate aminotransferase levels.
  • Viral studies were conducted.

Main Results:

  • All patients exhibited elevated serum creatine kinase and aspartate aminotransferase levels.
  • Two patients presented with leucopenia.
  • Viral studies were negative in all cases.
  • Full recovery was observed within 12 hours to 3 days for all patients.

Conclusions:

  • Benign acute childhood myositis is a self-limiting illness with a favorable prognosis.
  • Pediatricians and neurologists should be aware of BACM to differentiate it from other causes of gait disturbance.
  • The condition often occurs in winter epidemics, suggesting a potential viral etiology.
Abstract

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...